13F HOLDINGS REPORT
Essex Woodlands Management, Inc.
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001398344-24-020745
Total Value
$350.4M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MIMEDX GROUP, INC. | MDXG | 28,195,249 | $166.6M | 47.56% |
| 2 | BIOVENTUS | BVS | 13,021,324 | $155.6M | 44.41% |
| 3 | EYEPOINT PHARMACEUTICALS INC | EYPT | 1,551,521 | $12.4M | 3.54% |
| 4 | TELA BIO, INC. | TELA | 4,110,709 | $10.4M | 2.97% |
| 5 | REVANCE THERAPEUTICS INC | 761330109 | 457,085 | $2.4M | 0.68% |
| 6 | MEDICINOVA INC | MNOV | 1,105,941 | $2.3M | 0.66% |
| 7 | VENUS CONCEPT, INC. | VERO | 1,089,190 | $664,842 | 0.19% |